A detailed history of Nalls Sherbakoff Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 675 shares of ABBV stock, worth $136,012. This represents 0.09% of its overall portfolio holdings.

Number of Shares
675
Previous 675 -0.0%
Holding current value
$136,012
Previous $101 Million 3.96%
% of portfolio
0.09%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 17, 2023

SELL
$144.61 - $166.54 $31,814 - $36,638
-220 Reduced 24.58%
675 $107 Million
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $62,669 - $77,288
805 Added 894.44%
895 $83,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $7,006 - $8,640
90 New
90 $71,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.